RAPT 8-K 2026-01-14

RAPT Therapeutics, Inc. (RAPT) 8-K dated 2026-01-14 — accession 0001193125-26-012284. This URL is the filing, not the RAPT hub.

RAPT Therapeutics, Inc. (RAPT) is a biotechnology company listed on US.

RAPT Therapeutics, Inc. filed a 8-K on 2026-01-14. Accession 0001193125-26-012284.

Cached items: 7.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported RAPT revenue for 2023-12-31 was $0. Net income was -$116.8M. Revenue was down 100.0% from 2022-12-31 to 2023-12-31. RAPT currently screens at market cap $132.1M.

Not investment advice. The RAPT SEC hub lists recent forms. The stock page is the research view.